Cannabis Bioscience International Holdings, Inc. (CBIH) Receivables (2023 - 2026)

Cannabis Bioscience International Holdings has disclosed Receivables across 4 years of filings, most recently posting $1266.0 for Q1 2026.

• In Q1 2026, Receivables fell 52.05% year-over-year to $1266.0; the TTM figure through Feb 2026 stood at $1266.0 (down 52.05% YoY), while the FY2025 annual figure was $15535.0, down 22.86% from the prior year.
• Receivables came in at $1266.0 for Q1 2026 at Cannabis Bioscience International Holdings, down from $21811.0 in the prior quarter.
• In the past five years, Receivables ranged from a high of $21811.0 in Q4 2025 to a low of $1266.0 in Q1 2026.
• Average Receivables over 4 years is $14263.8, with a median of $17041.0 recorded in 2024.
• Year-over-year, Receivables soared 102.38% in 2024 and slumped 84.51% in 2025.
• Over 4 years, Receivables stood at $19403.0 in 2023, then decreased by 28.78% to $13819.0 in 2024, then soared by 57.83% to $21811.0 in 2025, then tumbled by 94.2% to $1266.0 in 2026.
• Per Business Quant data, the three most recent Receivables figures were $1266.0 in Q1 2026, $21811.0 in Q4 2025, and $18121.0 in Q3 2025.